glp receptor 1 agonists America's Poison Centers Targeting GLP-1, GIP & GCG

Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)

PMID: 34497589

Graham et al., 2020

PA requirements confirm that the members basal metabolic index (BMI) is consistent with product labeling (e.g., BMI 30 or a BMI 27 with comorbidities) and that the member has tried a comprehensive weight loss program including diet and increased physical activity

Despite the absence of adverse cardiovascular effects has been confirmed, this benefit was not verified in an integrated analysis of 12 controlled, randomized, short-term clinical trials (12-52 weeks) comparing exenatide with placebo or insulin [72]

Kunnumakkara, A